In ₹ Crore except Per Share Latest Annual	ORIENTTECH FY26	IZMO FY26	GENESYS FY26	EXPLEOSOL FY26	Peer Average
Valuation — at last close
P/E	188.50×	22.32×	23.88×	◆ 10.23×	18.81× +902%
P/B	2.57×	2.60×	◆ 1.12×	1.63×	1.79× +44%
EV/EBITDA	19.59×	20.32×	7.75×	◆ 5.25×	11.11× +76%
Market Cap	₹863 Cr	₹1,065 Cr	₹789 Cr	₹1,268 Cr	₹1,041 Cr -17%
Growth
Revenue CAGR 3Y	—	◆ 22.80%	21.86%	7.04%	17.23%
Revenue CAGR 5Y	—	23.00%	◆ 32.74%	29.78%	28.51%
Net Income CAGR 3Y	—	◆ 33.44%	29.99%	-2.53%	20.30%
Revenue YoY (latest Q)	—	◆ 15.70%	14.81%	12.29%	14.27%
Net Income YoY (latest Q)	—	◆ 103.12%	-24.30%	67.34%	48.72%
Profitability
EBITDA Margin	4.99%	18.28%	◆ 33.36%	15.34%	22.33% -78%
Net Income Margin	0.53%	◆ 16.70%	10.01%	11.19%	12.63% -96%
Return on Common Equity	1.37%	12.38%	5.17%	◆ 19.89%	12.48% -89%
Return on Capital Employed	8.52%	8.79%	6.73%	◆ 19.05%	11.52% -26%
Return on Assets	0.83%	10.21%	3.75%	◆ 14.09%	9.35% -91%
Credit & Quality
Total Debt/Equity	0.18×	0.01×	0.23×	◆ 0.00×	0.08× +125%
Interest Coverage	5.61×	21.23×	3.56×	◆ 63.37×	29.39× -81%
Scale — latest FY
Revenue / Total Income	₹870 Cr	₹285 Cr	₹328 Cr	₹1,108 Cr	₹574 Cr +52%
Net Income	₹4.6 Cr	₹47.6 Cr	₹32.8 Cr	₹124 Cr	₹68.1 Cr -93%
Total Assets	₹570 Cr	₹494 Cr	₹972 Cr	₹929 Cr	₹798 Cr -29%
EPS	₹1	₹31.89	₹7.91	₹79.89	₹39.9 -97%
Book Value per Share	₹73.44	₹273.33	₹168.35	₹500.2	₹313.96 -77%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.